# Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines

> **NCT01814670** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 185 (actual)

## Conditions studied

- Glabellar Rhytides

## Interventions

- **BIOLOGICAL:** botulinum toxin Type A

## Key facts

- **NCT ID:** NCT01814670
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-06
- **Primary completion:** 2014-07-31
- **Final completion:** 2014-10-29
- **Target enrollment:** 185 (ACTUAL)
- **Last updated:** 2019-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01814670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01814670, "Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01814670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*